Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples